VeraCept
Description: VeraCept is an IUD product. The arms of the product can compress inward with pressure from the uterine walls (unlike a plastic T-shaped device). It contains 175mm2 of copper surface and a flexible nitinol frame measuring 30mm in width x 32mm in height.
Product Details
Regimen:
Dose: 175 mm2
Active Pharmaceutical Ingredient (API):
Inactive material: Nitinol (nickel and titanium composite material) wire
Status Details
Status Details: - A prospective study of the safety, feasibility and effectiveness of the VeraCept as compared to a concurrently available standard copper IUD (TCu380) ended in 2015. A prospective, multi-center, single-arm, open-label, Phase II clinical study to evaluate the effectiveness, device placement, safety, and tolerability of VeraCept began in 2015. In addition to Phase 2 Clinical Trials in the United States, Veracept is preparing for CE Mark Application in the European Union.
- A prospective study of the safety, feasibility and effectiveness of the VeraCept as compared to a concurrently available standard copper IUD (TCu380) ended in 2015. A prospective, multi-center, single-arm, open-label, Phase II clinical study to evaluate the effectiveness, device placement, safety, and tolerability of VeraCept began in 2015. In addition to Phase 2 Clinical Trials in the United States, Veracept is preparing for CE Mark Application in the European Union.
Additional Information
References: Contramed website: https://www.contramed.com/veracept/overview/
ClinicalTrials.gov Identified NCT02167763
ClinicalTrials.gov Identified NCT02446821
Contramed website: https://www.contramed.com/veracept/overview/
ClinicalTrials.gov Identified NCT02167763
ClinicalTrials.gov Identified NCT02446821